Функциональное состояние респираторной системы после перенесенной COVID-19
DOI:
https://doi.org/10.54500/2790-1203-2024-2-121-12-17Ключевые слова:
респираторные нарушения, постковидный синдром, респираторная функция, исследование диффузионной способности легких по монооксиду, спирометрияАннотация
Респираторные расстройства относятся к самым частым cостояниям после перенесенной СOVID-19 наряду с повышенной утомляемостью, бессонницей, депрессивными растройствами, расстройством внимания и памяти. Частота респираторных растройств после перенесенной СOVID-19 в среднем составляет 35%.
Цель обзора: изучить в доступной литературе характеристику и длительность функциональных нарушений дыхания в постковидном периоде.
Исследованию постковидных нарушений посвящено множество работ, в том числе оценке функционального состояния дыхательной системы с использованием различных диагностических методов, функциональных тестов. Однако остается не ясным, сколько времени сохраняются нарушения респираторных параметров у пациентов, перенесших инфекцию COVID-19, и какие факторы влияют на их динамику.
Скачивания
Библиографические ссылки
WHO. WHO Coronavirus (COVID-19) Dashboard. Website. [Cited 26 Dec 2023]. Available from URL: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/
Информация о заболеваемости коронавирусной инфекцией в РК на 01.04.2022 год. Министерство
здравоохранения Республики Казахстан. Веб-сайт. [Дата обращения: 26 Дек. 2023]. Режим доступа: https://www.
gov.kz/memleket/entities/dsm/press/news/details/349074?lang=ru
Informacija o zabolevaemosti koronavirusnoj infekciej v RK na 01.04.2022 god. Ministerstvo zdravoohranenija
Respubliki Kazahstan (Information on the incidence of coronavirus infection in the Republic of Kazakhstan as of 01.04.2022. Ministry of Health of the Republic of Kazakhstan) [in Russian]. Veb-sajt. [Data obrashhenija: 26 Dek. 2023]. Rezhim dostupa: https://www.gov.kz/memleket/entities/dsm/press/news/details/349074?lang=ru
Hui D.S., Azhar E.I., Kim Y.J. Middle East respiratory syndrome coronavirus: risk factors and determinants of primary,
household, and nosocomial transmission. Lancet Infect Dis. 2018; 18(8): e217-e227.
Ahmed H., Patel K., Greenwood D.C. Long-term clinical outcomes in survivors of severe acute respiratory syndrome
and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: A systematic review and meta-analysis. J Rehabil Med. 2020; 52(5): jrm00063.
Chan J.F., Yuan S., Kok K.H., et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating
person-to-person transmission: a study of a family cluster. Lancet. 2020; 395(10223): 514-523.
Elrobaa I. H., New K. J. COVID-19: Pulmonary and Extra Pulmonary Manifestations. Frontiers in public health, 2021; 9: 711616.
Yelin D., Wirtheim E., Vetter P., et al. Long-term consequences of COVID-19: research needs. The Lancet. Infectious
diseases, 2020; 20(10): 1115–1117.
Lam M.H., Wing Y.K., Yu M.W., et al. Mental morbidities and chronic fatigue in severe acute respiratory syndrome
survivors: long-term follow-up. Arch Intern Med. 2009; 169(22): 2142-7.
Greenhalgh T., Knight M., A'Court C., et al. Management of post-acute covid-19 in primary care. BMJ. 2020; 370: m3026.
Белоцерковская Ю.Г., Романовских А.Г., Смирнов И.П. Долгий COVID-19 // Consilium Medicum. 2021. - №23 (3). - С. 261-268.
Belocerkovskaja Ju.G., Romanovskih A.G., Smirnov I.P., Sinopal'nikov A.I. Dolgij COVID-19 (Long COVID-19) [in Russian].
Consilium Medicum. 2021; 23 (3): 261–268.
Xiong Q., Xu M., Li J., Liu Y., et al. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal
study. Clinical microbiology and infection, 2021; 27(1): 89-95.
Petersen M. S., Kristiansen M. F., Hanusson K. D., Danielsen M. E., et al. Long COVID in the Faroe Islands: a longitudinal
study among nonhospitalized patients. Clinical infectious diseases, 2021; 73(11): e4058-e4063.
Nasserie T., Hittle M., Goodman S.N. Assessment of the Frequency and Variety of Persistent Symptoms Among Patients
With COVID-19: A Systematic Review. JAMA Netw Open. 2021; 4(5): e2111417.
Crook H., Raza S., Nowell J., et al. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374:n1648.
Mahmud R., Rahman M.M., Rassel M.A., et al. Post-COVID-19 syndrome among symptomatic COVID-19 patients: A
prospective cohort study in a tertiary care center of Bangladesh. PLOS ONE, 2021; 16(4): e0249644.
Pavli A., Theodoridou M., Maltezou H.C. Post-COVID Syndrome: Incidence, Clinical Spectrum, and Challenges for Primary Healthcare Professionals. Arch Med Res. 2021; 52(6): 575-581.
Woo M. S., Malsy J., Pöttgen J., Seddiq Zai S., et al, Frequent neurocognitive deficits after recovery from mild COVID-19,
Brain Communications, 2020; 2(2): fcaa205.
Augustin M., Schommers P., Stecher M., et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a
longitudinal prospective cohort study. Lancet Reg Health Eur. 2021; 6: 100122.
Carfì A., Bernabei R., Landi F. Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020; 324(6): 603-605.
Armange L., Bénézit F., Picard L., et al. Prevalence and characteristics of persistent symptoms after non-severe COVID-19: a prospective cohort study. Eur J Clin Microbiol Infect Dis. 2021; 40(11): 2421-2425.
Bastola A., Nepal R., Shrestha B., et al. Persistent Symptoms in Post-COVID-19 Patients Attending Follow-Up OPD at
Sukraraj Tropical and Infectious Disease Hospital (STIDH), Kathmandu, Nepal. Trop Med Infect Dis. 2021; 6(3): 113.
Kayaaslan B., Eser F., Kalem A.K., et al. Post-COVID syndrome: A single-center questionnaire study on 1007 participants
recovered from COVID-19. J Med Virol. 2021; 93: 6566- 6574.
Lemhöfer C., Sturm C., Loudovici-Krug D. et al. The impact of Post-COVID-Syndrome on functioning – results from a
community survey in patients after mild and moderate SARS-CoV-2-infections in Germany. J Occup Med Toxicol, 2021; 16: 45.
van der Sar-van der Brugge S, Talman S, Boonman-de Winter L, et al. Pulmonary function and health-related quality
of life after COVID-19 pneumonia. Respir Med. 2021; 176: 106272.
Mo X., Jian W., Su Z., et al. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur Respir J. 2020;55(6):2001217.
Okan S., Okan F., Yücesoy F. D. Evaluation of pulmonary function and exercise capacity after COVID-19 pneumonia.
Heart & lung : the journal of critical care,2022; 54: 1-6.
Smet J., Stylemans D., Hanon S., et al. Clinical status and lung function 10 weeks after severe SARS-CoV-2 infection.
Respir Med. 2021;176: 106276.
Huang Y., Tan C., Wu J. et al. Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase.
Respir Res, 2020; 21: 163.
Liao X., Wang Y., He Z., et al. Three-Month Pulmonary Function and Radiological Outcomes in COVID-19 Survivors: A
Longitudinal Patient Cohort Study. In Open forum infectious diseases, 2021; 8(9): ofaa540.
Frija-Masson J., Debray M.P., Gilbert M., et al. Functional characteristics of patients with SARS-CoV-2 pneumonia at
days post-infection. Eur Respir J. 2020; 56(2): 2001754.
Salem A.M., Al Khathlan N., Alharbi A.F., et al. The Long-Term Impact of COVID-19 Pneumonia on the Pulmonary
Function of Survivors. Int J Gen Med. 2021; 14: 3271-3280.
Cortés-Telles A., López-Romero S., Figueroa-Hurtado E., et al. Pulmonary function and functional capacity in COVID-19
survivors with persistent dyspnoea. Respir Physiol Neurobiol. 2021; 288: 103644.
Lerum T.V., Aaløkken T.M., Brønstad E., et al. Dyspnoea, lung function and CT findings 3 months after hospital admission for COVID-19. Eur Respir J. 2021; 57(4): 2003448.
Sibila O., Albacar N., Perea L., et al. Lung Function sequelae in COVID-19 Patients 3 Months After Hospital Discharge.
Arch Bronconeumol. 2021; 57: 59-61.
Froidure A., Mahsouli A., Liistro G., et al. Integrative respiratory follow-up of severe COVID-19 reveals common
functional and lung imaging sequelae. Respir Med. 2021; 181:106383.
Van den Borst B., Peters J.B., Brink M., et al. Comprehensive Health Assessment 3 Months After Recovery From Acute
Coronavirus Disease 2019 (COVID-19). Clin Infect Dis. 2021;73(5): e1089-e1098.
Zhao Y.M., Shang Y.M., Song W.B., et al. Follow-up study of the pulmonary function and related physiological
characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. 2020; 25: 100463.
Méndez R., Latorre A., González-Jiménez P., et al. Reduced Diffusion Capacity in COVID-19 Survivors. Ann Am Thorac Soc. 2021;18(7):1253-1255.
Anastasio F., Barbuto S., Scarnecchia E., et al. Medium-term impact of COVID-19 on pulmonary function, functional
capacity and quality of life. Eur Respir J. 2021; 58(3): 2004015.
Савушкина О.И., Черняк А.В., Крюков Е.В., и другие. Динамика функционального состояния системы дыхания
через 4 месяца после перенесенного COVID-19 // Пульмонология. 2021. - № 31 (5).- С. 580–587.
Savushkina O.I., Chernjak A.V., Krjukov E.V., Aseeva N.A., Zajcev A.A. Dinamika funkcional'nogo sostojanija sistemy
dyhanija cherez 4 mesjaca posle perenesennogo COVID-19 (Dynamics of the functional state of the respiratory system 4 months after COVID-19) [in Russian]. Pul'monologija. 2021; 31 (5): 580–587.
Safont B., Tarraso J., Rodriguez-Borja E., et al. Lung Function, Radiological Findings and Biomarkers of Fibrogenesis
in a Cohort of COVID-19 Patients Six Months After Hospital Discharge. Arch Bronconeumol. 2022; 58(2):142-149.
Huang C., Huang L., Wang Y., et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort
study. Lancet. 2021 Jan 16;397(10270):220-232.
Ekbom E., Frithiof R., Öi E., Larson I. M., et al. Impaired diffusing capacity for carbon monoxide is common in critically
ill Covid-19 patients at four months post-discharge. Respiratory medicine, 2021; 182: 106394.
Robey R.C., Kemp K., Hayton P., et al. Pulmonary Sequelae at 4 Months After COVID-19 Infection: A Single-Centre
Experience of a COVID Follow-Up Service. Adv Ther. 2021; 38(8): 4505-4519.
Cassar M.P., Tunnicliffe E.M., Petousi N., et al. Symptom Persistence Despite Improvement in Cardiopulmonary Health -
Insights from longitudinal CMR, CPET and lung function testing post-COVID-19. EClinicalMedicine. 2021; 41: 101159.
Lindahl A., Reijula J., Malmberg L.P. et al. Small airway function in Finnish COVID-19 survivors. Respir Res, 2021; 22: 237.
Vargas Centanaro G., Calle Rubio M., Álvarez-Sala Walther J.L., et al. Long-term Outcomes and Recovery of Patients who Survived COVID-19: LUNG INJURY COVID-19 Study. Open Forum Infect Dis. 2022; 9(4): ofac098.
Steinbeis F., Thibeault C., Doellinger F., et al. Severity of respiratory failure and computed chest tomography in acute
COVID-19 correlates with pulmonary function and respiratory symptoms after infection with SARS-CoV-2: An observational
longitudinal study over 12 months. Respir Med. 2022; 191: 106709.
Wu X., Liu X., Zhou Y., et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following
COVID-19-related hospitalisation: a prospective study. Lancet Respir Med. 2021;9(7):747-754.
Huang L., Yao Q., Gu X., et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study.
Lancet. 2021;398(10302):747-758.
